Publications by authors named "Jenafir House"

Claim this Profile
C
Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Teshome Gebre, Berhan Ayele, Mulat Zerihun, Asrat Genet, Nicole E Stoller, Jenafir I House

Lancet· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for ocular chlamydia after three mass azithromycin distributions.
Berhan Ayele, Teshome Gebre, Jeanne Moncada, Jenafir I House, Nicole E Stoller

PLoS Negl Trop Dis· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.
Teshome Gebre, Berhan Ayele, Mulat Zerihun, Jenafir I House, Nicole E Stoller

Am J Trop Med Hyg· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events after mass azithromycin treatments for trachoma in Ethiopia.
Berhan Ayele, Teshome Gebre, Jenafir I House, Zhaoxia Zhou, Charles E McCulloch

Am J Trop Med Hyg· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.
Nicole E Stoller, Teshome Gebre, Berhan Ayele, Mulat Zerihun, Yared Assefa, Jenafir I House

Int Health· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood mortality in a cohort treated with mass azithromycin for trachoma.
Jeremy D Keenan, Berhan Ayele, Teshome Gebre, Mulat Zerihun, Zhaoxia Zhou, Jenafir I House

Clin Infect Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slow resolution of clinically active trachoma following successful mass antibiotic treatments.
Jeremy D Keenan, Takele Lakew, Wondu Alemayehu, Muluken Melese, Jenafir I House

Arch Ophthalmol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
Sara Haug, Takele Lakew, Gabremaskal Habtemariam, Wondu Alemayehu, Vicky Cevallos, Jenafir House

Clin Infect Dis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
Takele Lakew, Jenafir House, Kevin C Hong, Elizabeth Yi, Wondu Alemayehu

PLoS Negl Trop Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
Jeremy D Keenan, Takele Lakew, Wondu Alemayehu, Muluken Melese, Travis C Porco, Jenafir I House

Am J Trop Med Hyg· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travel and implications for the elimination of trachoma in ethiopia.
Neelima A Shah, Jenafir House, Takele Lakew, Wondu Alemayehu, Colleen Halfpenny

Ophthalmic Epidemiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Jesse B Biebesheimer, Jenafir House, Kevin Cyrus Hong, Takele Lakew, Wondu Alemayehu

Ophthalmology· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
Travis C Porco, Teshome Gebre, Berhan Ayele, Jenafir House, Jeremy Keenan

JAMA· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
Takele Lakew, Wondu Alemayehu, Muluken Melese, Elizabeth Yi, Jenafir I House

PLoS Negl Trop Dis· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.
Kevin Cyrus Hong, Julius Schachter, Jeanne Moncada, Zhaoxia Zhou, Jenafir House

Emerg Infect Dis· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
Jenafir I House, Berhan Ayele, Travis C Porco, Zhaoxia Zhou, Kevin C Hong

Lancet· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
Jon L Yang, Kevin C Hong, Julius Schachter, Jeanne Moncada, Takele Lekew, Jenafir I House

Invest Ophthalmol Vis Sci· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete elimination is a difficult goal for trachoma programs in severely affected communities.
Deborah A Gill, Takele Lakew, Wondu Alemayehu, Muluken Melese, Zhaoxia Zhou, Jenafir I House

Clin Infect Dis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
Muluken Melese, Wondu Alemayehu, Takele Lakew, Elizabeth Yi, Jenafir House

JAMA· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real challenge: can we discover why trachoma is disappearing before it's gone?
Jenafir House, Bruce Gaynor, Hugh Taylor, Tom M Lietman

Int Ophthalmol Clin· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rationale for continuing mass antibiotic distributions for trachoma.
Kathryn J Ray, Travis C Porco, Kevin C Hong, David C Lee, Wondu Alemayehu, Jenafir House

BMC Infect Dis· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma.
Jon L Yang, Julius Schachter, Jeanne Moncada, Dereje Habte, Mulat Zerihun, Jenafir I House

Br J Ophthalmol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
Jaya D Chidambaram, Wondu Alemayehu, Muluken Melese, Takele Lakew, Elizabeth Yi, Jenafir House

JAMA· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis